We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I believe ICMR and the 1m order will come in the next 30 days, the GDR order is ready to go pending ICMR. Only formalities remain to close that deal otherwise it would not make it to the RNS. Also once other approvals come we will get a decent rise. So basically 1 month from now a LOT will be happening - I hope. And that will be the companies tentative expectations too.
Our biggest issue here isnt the lost sentiment, its the rampers who said we were going to £3, £5 next week. The hype has lost us money, their ramps have lost us money. To be fair DB has offered no ramps, it took me a while to digest this. Yes there was the use of the word significant in the VOX conference. That's the only part I had an issue with, and to be fair he announced 1m order subject to approvals. ODX announced 0.1m order. Big difference.
We believed what we wanted to believe. So weve been spiked by them. I hope 30 days from now we will be in a much better stead than where we are today. 2 approvals potentially and 1 order for 1m. Whatever that translates into a SP, thats where we will be.
2m a month is nowhere near enough. That’s circa 350,000 tests at a production rate of 10,000 per hour....about 4 days work.
I'm of the view that into winter we will be doing 5m+ in rev per month.
Personally see the SP at 350+ but that'll be due to a mix of sales and sentiment.
But good summary Safy. Waiting game.
So to summarise, we are on the right track.
Things are out of GDR control as things stand, as everything is stuck on approvals, we cannot ship tests in readiness for sales until approvals come through.
I'm not good at MCAP calculations, but if we get regular sales of say 2m a month from Aug to Dec, what would be a fair SP?
Also i raised the question about the vaccine, and is the window narrowing for GDR to achieve sales.
The answer for vaccine is, if someone offered you a vaccine today would you take it? how many vaccines can they produce? what if there is an outbreak of a side effect, what happens to the vaccine program. These are all grey areas.
The sales model GDR and ODX have as well as AVCT is not sales until Dec 2020, it goes beyond that. AVCT dont have a test yet, ODX do have tests and appear to be slightly ahead of us. To counter that GDR also have their own products which will gain traction soon.
So i've been doing some digging and speaking to someone who's also invested in GDR for his thoughts. This is the current state of play that i believe to be an accurate assessment of where we are.
I've been told post CE, GDR will have applied for regulatory approvals at the earliest point. I think at a push we could level the accusation it was 2 weeks late based on where we are at the moment but given there was no CE for the software tool, this delay might be justified if they wanted to go to market with the software tool as well as the test as a unit.
LP alluded to this in his email comms with Walbrook. For ICMR there are lots of hoops we need to jump through before the tests go to lab. Import licences etc is just part of it. The test is now in the lab as we know, FM has confirmed this. Divoc are our partners in India and they will drive this and not GDR. Why the delay, well they dont just approve any ol' test in India, we know that from independently digging on here (kudos Samolly for the sums). the country is also under extreme pressure with their own Covid pandemic. Think of it like trying to get the attention of the PHE at our peak, except they have 1.2bn people there and things are a lot worse than we had. You ever tried going through an Indian airport, if yes you will know what i mean.
I've spoken to an early NCYT investor and i've been told that in the early days FDA used to take a day for approval. However at the moment its somewhere around 2 months. I wrote around 45 days a day or two ago and that seems to be correct (working days). Its been a month already, so max tentative timescales indicate its another 3-4 weeks away, maybe sooner. FDA have been chased up based on my comms with the PR office but FDA wont disclose dates to GDR.
During approval stages, the labs dont just take your data, test and come back with a yes or no. They evaluate, they ask questions, they sometimes need more information. They sometimes want more tests. Given the state of play in India, the ICMR testing program has around 14 labs involved and there is data travelling back and forth within potentially all 14 centres involved in the approval process. GDR have stated on the record they are confident of getting this approval. Our validation has started and is well underway there.
I can say with a degree of certainty that the 1m sales order is for India. That's the furthest we are in the approvals so likelihood is those are Indian sales. 1m sales is around 125k tests @ £8 a test or more based on lower cost for sales. Once word spreads more tests will come.
NHS I dont think we are in there in the short term, its something GDR have submitted into (source Crowdcity), NHS / PHE are fully geared up at the moment, if the incumbents are removed for some reason that might work for us. The company has never publicly said they are trying to sell to the NHS, the last RNS also doesnt say that.